Last updated: December 30, 2024
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a specific drug identified by its NDC (National Drug Code), it is crucial to understand what the NDC represents. The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug. For the NDC 66993-0362, each segment provides specific information:
- Labeler Code: The first segment (66993) is assigned by the FDA and identifies the firm that manufactures, repackages, or relabels the drug.
- Product Code: The second segment identifies a specific strength, dosage form, and formulation for the particular firm.
- Package Code: The third segment identifies the package sizes and types[1][4].
Market Context
Drug Price Inflation
The pharmaceutical market is experiencing ongoing price inflation. According to Vizient's summer Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be 3.81%. This inflation is partly driven by expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2].
Price Increase Trends
Historically, most prescription drug price increases occur in January and July. In 2022, the average price increase in January was nearly $150 per drug (10% increase), and in July, it was $250 (7.8% increase). These increases are often higher for more expensive drugs, resulting in larger dollar increases but smaller percentage increases[5].
Specific Drug Analysis
Identifying the Drug
To analyze the market and price projections for NDC 66993-0362, one must first identify the drug associated with this code. This involves checking the FDA's National Drug Code Directory, which contains information on active and certified finished and unfinished drugs submitted by labelers[4].
Market Demand and Competition
The demand for the drug and the level of competition in its therapeutic class are critical factors in price projections. For example, if the drug is used to treat a condition with a growing prevalence, such as plaque psoriasis, the market demand is likely to increase. The launch of new pipeline agents and increased treatment options can also impact market dynamics[3].
Price Projections
Historical Price Changes
Analyzing historical price changes for the drug can provide insights into future price trends. If the drug has experienced significant price increases in the past, especially during the typical price increase months of January and July, it may continue to follow this pattern. However, regulatory changes, such as those introduced by the Inflation Reduction Act (IRA), may slow the rate of price increases[5].
Regulatory Impact
The IRA and other legislative measures aimed at reducing drug prices can significantly impact future price projections. For instance, the IRA includes policies that may reduce the rate of price increases for drugs, starting from the new rebate period beginning October 1, 2022[5].
Market Forecast
Given the overall trend of drug price inflation and the specific factors affecting the drug's market, here are some key points to consider:
- Inflation Rate: The projected 3.81% drug price inflation rate for 2025 suggests that prices for most drugs, including NDC 66993-0362, are likely to increase.
- Regulatory Impact: The IRA and other regulatory measures may mitigate the extent of these increases.
- Market Demand: Growing demand due to expanding indications or increased prevalence of the treated condition could drive prices up.
- Competition: The introduction of new drugs or biosimilars in the same therapeutic class could reduce prices due to increased competition.
Example: Plaque Psoriasis Market
To illustrate the impact of these factors, consider the plaque psoriasis market. By 2030, the sales for plaque psoriasis treatments are expected to grow to $31.7 billion, with a compound annual growth rate (CAGR) of 10.6%. This growth is driven by new pipeline agents and increased treatment options. However, the loss of patent protection for biologics and the launch of generics and biosimilars will also influence pricing[3].
Key Takeaways
- NDC Identification: The NDC 66993-0362 uniquely identifies a drug product, including its labeler, product specifics, and package size.
- Market Trends: Drug prices are expected to rise, with a projected 3.81% inflation rate for 2025.
- Regulatory Impact: The IRA and other legislative measures may slow the rate of price increases.
- Market Demand and Competition: Growing demand and competition from new drugs or biosimilars can significantly impact price projections.
- Historical Price Changes: Analyzing past price increases can help predict future trends.
FAQs
-
What does the National Drug Code (NDC) represent?
- The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug.
-
When do most prescription drug price increases occur?
- Most prescription drug price increases occur in January and July each year.
-
How does the Inflation Reduction Act (IRA) impact drug prices?
- The IRA includes policies aimed at reducing drug prices, which may slow the rate of price increases starting from the new rebate period.
-
What factors influence the price projections for a specific drug?
- Historical price changes, market demand, competition, and regulatory changes are key factors influencing price projections.
-
How can market demand affect drug prices?
- Growing demand due to expanding indications or increased prevalence of the treated condition can drive prices up, while increased competition from new drugs or biosimilars can reduce prices.
Sources
- FDA - National Drug Code Database Background Information
- Vizient - Vizient projects drug price inflation at 3.81%
- GlobeNewswire - Plaque Psoriasis Drug Forecast and Market Analysis to 2030
- FDA - National Drug Code Directory
- ASPE - Price Increases for Prescription Drugs, 2016-2022
